We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App





Mindray Showcases Comprehensive IVD Solutions Portfolio at MEDLAB Middle East 2020

By LabMedica International staff writers
Posted on 06 Feb 2020
Print article
Illustration
Illustration
Mindray (Shenzhen, China) showcased its range of in-vitro diagnostic products at MEDLAB 2020, including its CAL 6000 Cellular Analysis Line, SAL 9000 Modular System, CL-900i Chemiluminescence lmmunoassay System and BC-5150 Auto Hematology Analyzer.

Over 25,800 medical laboratory industry professionals and 600 exhibitors from 35 countries met in Dubai for MEDLAB Middle East, the Middle East & North Africa (MENA) region’s largest medical laboratory exhibition and congress, which took place from 3-6 February 2020 at the Dubai World Trade Centre.

At this year’s MEDLAB, Mindray showcased its CAL 6000 Cellular Analysis Line which combine two units of BC-6000 or BC-6200 auto hematology analyzers and one unit of SC-120 to deliver a throughput of up to 220 tests per hour and 120 slides per hour. The CAL 6000 is equipped with three loading platforms and three unloading platforms with large capacities. The bidirectional loading track, with patent technology, on the first hematology analyzer enables fast sample distribution, improving efficiency and productivity. Should the sample results trigger the criteria, the autoloader of each hematology analyzer will return the sample racks for automatic rerun or reflex check.

Mindray also presented its SAL 9000 Modular System which delivers high throughputs of chemistry and immunoassay testing by integrating its BS-2000 Chemistry Analyzer and CL-6000i Chemiluminescence Immunoassay Analyzer, and new Sample Processing System SPL 2000. With patented automatic serum analysis design, SAL 9000 helps optimize the management of lab space and manpower, and also offers highly reliable test results.

Additionally, Mindray showcased the CL-900i, one of the world’s smallest, fully automated chemiluminescence immunoassay analyzers, that integrates a large capacity and fast assay speed into a compact model, achieving a perfect balance between size and immunoassay testing performance. The CL-900i has a throughput of up to 180 tests/hour, and offers 50 sample positions and 15 reagent positions.

At MEDLAB Middle East, Mindray exhibited the BC-5150 Auto Hematology Analyzer which is especially tailored to assist diagnostic labs that need full CBC + 5-part results, with relatively low daily sample volume, restricted lab space and tight budget. As the lightest and most compact 5-part hematology analyzer so far from Mindray, BC-5150 is a highly user-friendly and innovative, offering cost-efficient CBC and 5-part white cell differential results.

Related Links:
Mindray

New
Gold Member
Chagas Disease Test
CHAGAS Cassette
Gold Member
Troponin T QC
Troponin T Quality Control
New
RNA Isolation Kits
RNeasy Plus Kits for RNA Isolation
New
Microplates
Eppendorf Microplates

Print article

Channels

Immunology

view channel
Image: Example image of the high-throughput microscopy method used in the study, showing immune cells stained with different fluorescence markers (Photo courtesy of Felix Kartnig/CeMM, MedUni Vienna)

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Rheumatoid arthritis is the most common inflammatory joint disorder, with women three times as likely to suffer from the condition as men. Treatment advances made over the past decades have led to the... Read more

Microbiology

view channel
Image: RNA sequencing directly from whole blood aims to expand access to LRTI testing (Photo courtesy of CARB-X)

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.